Group 1 - The core viewpoint of the article highlights that MicroPort Robotics (02252) has seen a stock increase of over 4%, currently trading at HKD 32.16 with a transaction volume of HKD 862 million [1] - The company anticipates a revenue growth of approximately 110% to 120% year-on-year for the fiscal year ending December 31, 2025, with an adjusted net loss not exceeding RMB 240 million, representing a reduction of over 50% compared to the previous year [1] - As of the announcement date, the company has accumulated over 180 commercial orders globally and has surpassed 120 units in commercial installations [1] Group 2 - On January 20, the National Healthcare Security Administration released guidelines for pricing surgical and therapeutic auxiliary medical services, establishing a unified pricing framework for surgical robots, energy devices, and remote surgery technologies [1] - Everbright Securities believes that the surgical robot industry has significant potential and low penetration rates, and the increased clarity in policies injects new momentum for industry growth [1]